Cargando…
Model-based Cost-effectiveness Analysis of Atorvastatin Drugs for Prevention of Cardiovascular Diseases in Iran
BACKGROUND: Today, cardiovascular disease is one of the main causes of mortality and disability in most developed and developing countries. The prediction of the major causes of deaths all over the world at all ages shows that 61% of deaths are due to chronic diseases, of which 30% is due to cardiov...
Autores principales: | Jabbari, Alireza, Jafari, Abdosaleh, Hadian, Marziye, Ghasemi, Mohammad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7297424/ https://www.ncbi.nlm.nih.gov/pubmed/32577187 http://dx.doi.org/10.4103/ijpvm.IJPVM_578_18 |
Ejemplares similares
-
The Cost-Effectiveness and Cost-Utility of Statin Drug for the Treatment of Patients with Cardiovascular Disease, A Systematic Review
por: Eisavi, Mahmoud, et al.
Publicado: (2021) -
The economic cost of cancer treatment in Iran
por: Jabbari, Alireza, et al.
Publicado: (2023) -
Iran's Struggling Health System: An Increase in Natural Childbirth: A Case Study
por: Jabbari, Alireza, et al.
Publicado: (2018) -
Workplace violence and influencing factors among paramedic pre hospital paramedic personnel (city and road) in Iran: a quality content analysis
por: Hadian, Marziye, et al.
Publicado: (2021) -
What is the impact of clinical guidelines on imaging costs?
por: Hadian, Marziye, et al.
Publicado: (2021)